Study record managers: refer to the Data Element Definitions if submitting registration or results information.
|1||NCT00972478||Active, not recruiting
|Vorinostat, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma||
||83||All||18 Years and older (Adult, Senior)||NCT00972478||NCI-2011-01964
|November 2010||December 2015||September 7, 2009||October 13, 2017||October 31, 2016||